Changzhou Qianhong Biopharma Co., Ltd. (002550) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Changzhou Qianhong Biopharma Co., Ltd.

Why is Changzhou Qianhong Biopharma Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -5.02% and Operating profit at 43.89% over the last 5 years

Negative results in Mar 26

NET SALES(Q) At CNY 358.08 MM has Fallen at -20.58%
PRE-TAX PROFIT(Q) At CNY 99.47 MM has Fallen at -46.37%
NET PROFIT(Q) At CNY 82.32 MM has Fallen at -48.44%

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 16.83% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -27.08% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Changzhou Qianhong Biopharma Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Changzhou Qianhong Biopharma Co., Ltd.

-31.63%

0.60

38.05%

China Shanghai Composite

3.23%

1.20

14.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-5.02%

EBIT Growth (5y)

43.89%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.40

Sales to Capital Employed (avg)

0.59

Tax Ratio

17.77%

Dividend Payout Ratio

46.07%

Pledged Shares

Institutional Holding

ROCE (avg)

16.61%

ROE (avg)

8.97%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.68

EV to EBIT

18.17

EV to EBITDA

15.76

EV to Capital Employed

4.05

EV to Sales

4.31

PEG Ratio

Dividend Yield

2.51%

ROCE (Latest)

22.30%

ROE (Latest)

10.31%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Sideways

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at -44.37 %

INVENTORY TURNOVER RATIO(HY)

Highest at 1.76 times

CASH AND EQV(HY)

Highest at CNY 2,530.9 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 4.15 times

-13What is not working for the Company

NET SALES(HY)

At CNY 758.37 MM has Grown at -12%

PRE-TAX PROFIT(Q)

At CNY 60.31 MM has Fallen at -42.48%

RAW MATERIAL COST(Y)

Grown by 22.79% (YoY

NET PROFIT(Q)

Fallen at -33.4%

Here's what is working for Changzhou Qianhong Biopharma Co., Ltd.

Debt-Equity Ratio

Lowest at -44.37 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio

Highest at 1.76 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Cash and Eqv

Highest at CNY 2,530.9 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio

Highest at 4.15 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Changzhou Qianhong Biopharma Co., Ltd.

Pre-Tax Profit

At CNY 60.31 MM has Fallen at -42.48%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Sales

At CNY 758.37 MM has Grown at -12%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Profit

Fallen at -33.4%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Raw Material Cost

Grown by 22.79% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales